Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHL TelemedicineSHMLF 52 Equity-to-Asset is 0.52 as of Dec. 2025, which is 2% above its 10-year median of 0.51. GuruFocus rates SHMLF with a GF Score™ of 52/100 and a GF Value™ of $12.09. The stock has 3 warning signs investors should review. Among 682 Healthcare Providers & Services companies, SHL Telemedicine ranks better than 53.08% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SHL Telemedicine's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $43.77 Mil. SHL Telemedicine's Total Assets for the quarter that ended in Dec. 2025 was $84.62 Mil.
Therefore, SHL Telemedicine's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.52.
The historical rank and industry rank for SHL Telemedicine's Equity-to-Asset or its related term are showing as below:
SHMLF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.38 Med: 0.51 Max: 0.68
Current: 0.52
During the past 13 years, the highest Equity to Asset Ratio of SHL Telemedicine was 0.68. The lowest was 0.38. And the median was 0.51.
SHMLF's Equity-to-Asset is ranked better than 53.08% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 0.485
vs SHMLF: 0.52
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
SHL Telemedicine Equity-to-Asset Related Terms
SHL Telemedicine Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for SHL Telemedicine's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHMLF vs VEEV, BTSG, TEM: Equity-to-Asset Comparison
For the Health Information Services subindustry, SHL Telemedicine's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SHL Telemedicine Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where SHL Telemedicine's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
SHL Telemedicine's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHL Telemedicine (SHMLF) has a Equity-to-Asset of 0.52 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SHL Telemedicine and its competitors. This is near median its historical median of 0.51. Over the past decade, SHL Telemedicine's Equity-to-Asset has ranged from 0.38 to 0.68. According to the industry distribution chart, SHL Telemedicine ranks #320 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 46.9%.
Is SHL Telemedicine's Equity-to-Asset too high?
SHL Telemedicine's current Equity-to-Asset of 0.52 is near median its 10-year median of 0.51. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 0.68. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. SHL Telemedicine's value of 0.52 is 7.2% above this industry median. Based on the distribution chart, SHL Telemedicine ranks #320 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, SHL Telemedicine has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Equity-to-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #320 out of 682 companies for Equity-to-Asset. This puts SHL Telemedicine in the upper half of its industry. The industry median Equity-to-Asset is 0.49. SHL Telemedicine's value of 0.52 is 7.2% above this benchmark. Historically, SHL Telemedicine's own Equity-to-Asset has ranged from 0.38 to 0.68 over the past decade. While the company's 10-year median is 0.51 vs. the industry median of 0.49, SHL Telemedicine has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SHL Telemedicine's current Equity-to-Asset of 0.52 is 7.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SHL Telemedicine and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SHL Telemedicine's current Equity-to-Asset is 0.52, which is near median its own 10-year median of 0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current Equity-to-Asset of 0.52. The stock's GF Value™ is $12.09, compared to a current price of $4.84 — trading 59.9% below its estimated fair value. The current Equity-to-Asset is 0.52, which is near median its 10-year median of 0.51 and 7.2% above the Healthcare Providers & Services industry median of 0.49. SHL Telemedicine's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current Equity-to-Asset is 0.52 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SHL Telemedicine (SHMLF) Overvalued in 2026?
Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued.
The current stock price of $4.84 is trading 59.9% below its estimated GF Value™ of $12.09.
Key valuation signals for SHMLF:
Equity-to-Asset: 0.52 (near median its 10-year median of 0.51)
GF Value™: $12.09 vs. price of $4.84 (59.9% below fair value)
Industry Position: 7.2% above the Healthcare Providers & Services median (#320 of 682)
No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
52GF Score
Get the complete analysis for SHMLF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHMLF has been successfully added to your 
